Pharmacological and Non-pharmacological therapies that modulare lung function decline

P. Calverley (Liverpool, United Kingdom)

Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today

Number: 8

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Calverley (Liverpool, United Kingdom). Pharmacological and Non-pharmacological therapies that modulare lung function decline. Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Therapeutic approaches to lung aging Source: International Congress 2016 – The future is now: the challenge of ageing in respiratory medicine Year: 2016
Treatment of COPD: from pharmacological to instrumental therapies Source: Eur Respir Rev 2009; 19: 7-23 Year: 2010
Non-pharmacological treatment Source: International Congress 2017 – Latest GOLD update Year: 2017
Non-pharmacological treatment Source: ERS Online Course 2016 Year: 2016
Non-pharmacological strategies to prevent hospitalisation in advanced stable COPD Source: International Congress 2019 – State of the art session: Respiratory critical care Year: 2019
Pharmacological and nonpharmacological interventions to improve symptom control, functional exercise capacity and quality of life in interstitial lung disease: an evidence synthesis Source: ERJ Open Res, 7 (1) 00107-2020; 10.1183/23120541.00107-2020 Year: 2021
Pharmacological treatments Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021
Pharmacological option for hyperinflation Source: International Congress 2014 – Severe lung hyperinflation: troubles and solutions Year: 2014
Pharmacological treatment Source: International Congress 2017 – Latest GOLD update Year: 2017
Cardiovascular effects of innovative therapies in lung cancer Source: Eur Respir Monogr 2020; 88: 154-166 Year: 2020
Novel lung function tests can improve phenotyping and differential therapy in COPD Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019
Non-pharmacological interventions for the management of breathlessness Source: International Congress 2018 – Dyspnoea: a multidimensional and multidisciplinary approach Year: 2018
Will we really achieve anti-ageing lung treatments? Abnormal lung ageing in COPD Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021
Pharmacological options for the treatment of COPD: present and future Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy Year: 2007
Chronic cough: Are we integrating non-pharmacological therapies into treatment plans? Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017